Home Beacon Biosignals

Beacon Biosignals

In operation
Series B
Developer of AI Platform for Neurological and Psychiatric Disorders Treatment
Basic
Enterprise Profile

Basic Information

Beacon's EEG Neurobiomarker Platform is designed to accelerate clinical trials and provide new treatment options for patients with neurological and psychiatric disorders. Through advanced machine learning algorithms, extensive datasets, and progress in software engineering, we are transforming the way patients address brain-related diseases.
Beacon Biosignals, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2019
--

Enterprise Profile

Industrial Sector
New Drug Development Information Technology Vendors
Technology
Machine Learning
Concept
# Brain Sciences Disease Treatment Mental Disorders # Nervous System Diseases
Application Scenarios
Innovative Drugs AI+Pharmaceuticals